Benefits and challenges of integrating nursing home residents into clinical trials

Clinical trials are constantly being designed and study participants enrolled to determine if medical treatments and therapies are safe and effective.

Almost a year since Humira biosimilars launched, AbbVie still controls more than 97% of the US market

AbbVie isn’t losing its control of its biggest cash cow Humira (adalimumab) quite yet, despite the influx of eight adalimumab biosimilars vying for market share,

October 11, 2023

J&J MedTech Chairman Ashley McEvoy to step down

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. This article has been updated with statements

October 24, 2023

FDA approves Takeda’s GAMMAGARD LIQUID for CIDP treatment

Share this article The FDA granted the approval based on data from Takeda’s ADVANCE-CIDP 2 clinical trial of GAMMAGARD LIQUID. Credit: Jonathan Weiss / Shutterstock.com.

January 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.